285 related articles for article (PubMed ID: 16778892)
1. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
[TBL] [Abstract][Full Text] [Related]
2. CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation.
Elcheva I; Goswami S; Noubissi FK; Spiegelman VS
Mol Cell; 2009 Jul; 35(2):240-6. PubMed ID: 19647520
[TBL] [Abstract][Full Text] [Related]
3. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.
Fuchs SY; Chen A; Xiong Y; Pan ZQ; Ronai Z
Oncogene; 1999 Mar; 18(12):2039-46. PubMed ID: 10321728
[TBL] [Abstract][Full Text] [Related]
4. Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-κB and β-catenin/TCF signaling pathways.
Wang L; Feng W; Yang X; Yang F; Wang R; Ren Q; Zhu X; Zheng G
Cell Death Dis; 2018 Apr; 9(4):427. PubMed ID: 29555946
[TBL] [Abstract][Full Text] [Related]
5. Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor.
Spiegelman VS; Slaga TJ; Pagano M; Minamoto T; Ronai Z; Fuchs SY
Mol Cell; 2000 May; 5(5):877-82. PubMed ID: 10882123
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
7. The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells.
Wang X; Adhikari N; Li Q; Guan Z; Hall JL
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):85-90. PubMed ID: 14592850
[TBL] [Abstract][Full Text] [Related]
8. Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma.
Lauscher JC; Gröne J; Dullat S; Hotz B; Ritz JP; Steinhoff U; Buhr HJ; Visekruna A
Mol Carcinog; 2010 Feb; 49(2):121-9. PubMed ID: 20027638
[TBL] [Abstract][Full Text] [Related]
9. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.
Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T
J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388
[TBL] [Abstract][Full Text] [Related]
10. Homodimer of two F-box proteins betaTrCP1 or betaTrCP2 binds to IkappaBalpha for signal-dependent ubiquitination.
Suzuki H; Chiba T; Suzuki T; Fujita T; Ikenoue T; Omata M; Furuichi K; Shikama H; Tanaka K
J Biol Chem; 2000 Jan; 275(4):2877-84. PubMed ID: 10644755
[TBL] [Abstract][Full Text] [Related]
11. IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2.
Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Suzuki T; Ichiyama A; Ikenoue T; Omata M; Furuichi K; Tanaka K
Biochem Biophys Res Commun; 1999 Mar; 256(1):127-32. PubMed ID: 10066435
[TBL] [Abstract][Full Text] [Related]
12. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HOS expression and activities by Wnt pathway.
Spiegelman VS; Tang W; Katoh M; Slaga TJ; Fuchs SY
Oncogene; 2002 Jan; 21(5):856-60. PubMed ID: 11850814
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mRNA-binding protein CRD-BP in malignant melanomas.
Elcheva I; Tarapore RS; Bhatia N; Spiegelman VS
Oncogene; 2008 Aug; 27(37):5069-74. PubMed ID: 18454174
[TBL] [Abstract][Full Text] [Related]
15. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs cross the line: the battle for mRNA stability enters the coding sequence.
Nielsen AF; Gloggnitzer J; Martinez J
Mol Cell; 2009 Jul; 35(2):139-40. PubMed ID: 19647510
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
[TBL] [Abstract][Full Text] [Related]
19. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
